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The potential reservoir role of serum and peripheral blood mononuclear cells
(PBMCs) for total HBV DNA (tDNA) and cccDNA still remains unknown.
Material and methods
We analyzed tDNA and cccDNA with a single sensitive and validated standardized
real-time PCR method in serum and PBMCs in two populations of chronic HBV
infection coinfected or not with HCV and/or HIV viruses: a retrospective cohort of
130 HBsAg-negative (HBsAg−) patients with “anti-HBc alone” or anti-HBc and anti-
HBs antibodies (Ab) and a cohort of 70 HBsAg-positive patients, 16 of them being
prospectively followed under treatment.
Results
Among HBsAg− patients, HBV DNA was detected in serum or PBMCs in about half
of the cases with various distributions of tDNA and cccDNA: in HIV-negative
patients with an “antiHBc alone” profile, tDNA was mostly detected in PBMCs
suggesting a possible active role of PBMCs; although cccDNA was not detected in
PBMCs in HIV-positive patients, tDNA and cccDNA were mostly observed in serum,
suggesting a specific pattern of more “persistent” than “occult” infection in this
population. Patients with anti-HBc and anti-HBs Ab harbored tDNA in serum or in
PBMCs, regardless of their HIV or HCV status, raising the question of a viral
reactivation risk during immunosupression in these patients. Among HBsAg+
patients, tDNA was detected in serum and PBMCs of 88.5% of the cases and
cccDNA in 22%. Levels of tDNA in both compartments were highly correlated
during treatment, suggesting a passive reservoir role for PBMCs.
Conclusion
The respective distribution of tDNA and cccDNA in serum and PBMCs may reflect
the different immune statuses of the host in HBsAg+ and HBsAg− patients. The
frequency of HBV DNA in PBMCs from AgHBs− patients suggests a viral
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